With 2 mL bacteriostatic water
20.0 units
Page last checked
Reconstitution · TB-500
Pick the vial, the water you added and the dose. Get the exact draw in units for the syringe in your hand.
Step 1 of 4
This vial holds 10 mg in total.
U-100 insulin syringe · 1 mL · lines every 2 units · 1 unit = 0.01 mL
30.0 units on a U-100 insulin syringe · 1 mL · lines every 2 units, which is 0.30 milliliters. The draw lands on a syringe line.
Your address is used to send this one card. The email also includes an optional link for updates when our data changes. Nothing else is sent unless you choose that link, and you can unsubscribe anytime.
TB-500 is a code name for material sold as thymosin beta-4, a protein your body releases where you are injured. The FDA says what is sold under the name is a seven-amino-acid piece of that protein. People buy it for the same injuries as BPC-157 — tendon, muscle and joint — and often buy the two together.
The full protein has been given to people in trials for eye, wound and heart conditions. The short piece sold as TB-500 has not. The FDA states it found no record of any person receiving it, by any route.
Each row uses 10 mg and the liquid volume shown. Dividing the amount by that volume gives the calculated concentration. The rows are arithmetic examples, not alternative product preparations.
With 2 mL bacteriostatic water
20.0 units
With 3 mL bacteriostatic water
30.0 units
| Bacteriostatic water | Concentration | Per U-100 unit | Draw for 1 mg | Nearest syringe line |
|---|---|---|---|---|
| 2 mL | 5.00 mg/mL | 50.0 mcg | 20.0 u · 0.200 mL | exactly 20 u |
| 3 mL | 3.33 mg/mL | 33.3 mcg | 30.0 u · 0.300 mL | exactly 30 u |
The amount, liquid volume and dose shown here are the calculator’s starting example for TB-500. Replace them with your own values. Every result in the table is calculated from those inputs.
The TB-500 guide distinguishes the fragment associated with this name from the full-length parent protein. Research on the full-length molecule does not establish a regimen for the fragment. A vial name alone cannot verify its contents.
A study can describe an amount accurately while still being about a different substance from the one a reader has in mind. That distinction is especially important when the parent protein and a shorter fragment appear in the same discussion.
The calculator has no way to identify a peptide or decide which research applies to a product. The linked compound guide explains the identity boundary. Converting an amount to syringe units does not remove it.
The TB-500 presets include two vial strengths. Holding the amount and water volume steady, the stronger vial produces a more concentrated solution and a smaller calculated draw. A remembered syringe reading cannot carry across that change unchanged.
The displayed examples fit within the selected barrel. Read the target volume and rounding output for the current setup rather than assuming that every different amount will also fit or land on a syringe line.
The theoretical number of draws comes from the vial total divided by the amount entered for each draw. Water changes concentration and draw volume. It does not add more TB-500 or increase that theoretical count.
A small supply count also says nothing about how long a preparation can be stored or which schedule is appropriate. Those are separate questions. The calculation cannot answer them by borrowing a regimen from the parent protein.
This page’s evidence review found no human dose that could be assigned to the TB-500 fragment. Work on full-length thymosin beta-4 does not automatically apply to this shorter peptide. The example entry is there to explain the math.
Similar names can refer to different peptide sequences. A dose from a study of the full-length peptide cannot become a TB-500 fragment dose just because the two names appear together online. The study material has to match.
A mass and a liquid volume are enough to work out a concentration. They are not enough to establish a dose. The tool can show the math while the page still states that it has no supported human dose to offer.
A supply duration requires both an amount per draw and a frequency. A sample amount does not supply either a validated schedule or a storage window. Those remain separate from the conversion.
Similar names can refer to different peptide sequences. A dose from a study of the full-length peptide cannot become a TB-500 fragment dose just because the two names appear together online. The study material has to match.
A mass and a liquid volume are enough to work out a concentration. They are not enough to establish a dose. The tool can show the math while the page still states that it has no supported human dose to offer.
A supply duration requires both an amount per draw and a frequency. A sample amount does not supply either a validated schedule or a storage window. Those remain separate from the conversion.
Mix 10 mg into 3 mL and one U-100 unit carries 33.3 mcg. The table shows how much peptide is in each numbered syringe line. These are conversion examples, not suggested doses.
| U-100 line | Volume | Mass (mcg) | Mass (mg) |
|---|---|---|---|
| 10 u | 0.10 mL | 333 mcg | 0.333 mg |
| 20 u | 0.20 mL | 667 mcg | 0.667 mg |
| 30 u | 0.30 mL | 1,000 mcg | 1 mg |
| 40 u | 0.40 mL | 1,333 mcg | 1.333 mg |
| 50 u | 0.50 mL | 1,667 mcg | 1.667 mg |
| 60 u | 0.60 mL | 2,000 mcg | 2 mg |
| 70 u | 0.70 mL | 2,333 mcg | 2.333 mg |
| 80 u | 0.80 mL | 2,667 mcg | 2.667 mg |
| 90 u | 0.90 mL | 3,000 mcg | 3 mg |
| 100 u | 1.00 mL | 3,333 mcg | 3.333 mg |
The math is only one part of the question. These guides cover the compound, published doses, side effects, mixing steps and supplies.